Ambien Cr
Product Images NDC 54868-5426

4 FDA label images from Physicians Total Care, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ambien Cr (NDC 54868-5426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle)

Principal Display Panel (12.5 mg Tablet Bottle)
Ambien CR 12.5 mg tablet label by Physicians Total Care, Inc. The label shows product name, active ingredient zolpidem tartrate ER, strength 12.5 mg, and package size of 90 tablets. It includes storage instructions, caution about federal law requiring prescription, and manufacturer information. The label also contains barcode and lot number sections.*
FDA Label Image

Principal Display Panel (6.25 mg Tablet Bottle)

Principal Display Panel (6.25 mg Tablet Bottle)
Ambien CR 6.25 mg extended-release tablets packaging label from Physicians Total Care, Inc., containing 30 tablets. The label includes cautionary text about federal law restrictions, storage instructions, and lot and expiration information.*
FDA Label Image

Chemical Structure (Ambien Cr 01)

Chemical Structure (Ambien Cr 01)
Chemical structure of the active ingredient in Ambien CR, showing detailed molecular diagrams including heterocyclic and aromatic components.*
FDA Label Image

Figure 1 (Ambien Cr 02)

Figure 1 (Ambien Cr 02)
A line graph showing zolpidem plasma concentrations (ng/mL) over time (hours) comparing 12.5 mg Ambien CR with 10 mg zolpidem tartrate immediate release. The 12.5 mg Ambien CR exhibits higher concentrations at later time points compared to the immediate release formulation, with concentration peaks occurring around 1.5 to 2 hours post-dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.